This announcement is a separate document:
普蕊斯：北京国枫律师事务所关于普蕊斯（上海）医药科技开发股份有限公司2022年限制性股票激励计划预留授予部分第一个解除限售期解除限售条件成就的法律意见书
Prius: Legal Opinion of Beijing Guofeng Law Firm on the 2022 Restricted Stock Incentive Plan of Pryce (Shanghai) Pharmaceutical Technology Development Co., Ltd. reserves and grants some of the first achievements of lifting the sales restriction conditions during the period of lifting the sales restrictions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated